Masimo Corporation (NASDAQ:MASI) – Stock analysts at Wedbush increased their FY2017 earnings estimates for Masimo Corporation in a research note issued to investors on Thursday. Wedbush analyst Levy. T now anticipates that the medical equipment provider will post earnings of $2.80 per share for the year, up from their prior estimate of $2.65. Wedbush has a “Outperform” rating and a $112.00 price target on the stock. Wedbush also issued estimates for Masimo Corporation’s FY2018 earnings at $2.74 EPS and FY2019 earnings at $3.24 EPS.

Other analysts also recently issued research reports about the stock. Stifel Nicolaus started coverage on shares of Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 target price for the company. Roth Capital lifted their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. BidaskClub upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Zacks Investment Research downgraded shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 11th. Six research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Masimo Corporation currently has a consensus rating of “Hold” and an average target price of $87.50.

TRADEMARK VIOLATION WARNING: “FY2017 EPS Estimates for Masimo Corporation Boosted by Analyst (NASDAQ:MASI)” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.dailypolitical.com/2017/08/05/fy2017-eps-estimates-for-masimo-corporation-boosted-by-analyst-nasdaqmasi.html.

Shares of Masimo Corporation (MASI) opened at 85.29 on Friday. The company has a 50 day moving average price of $93.60 and a 200-day moving average price of $89.40. Masimo Corporation has a one year low of $52.07 and a one year high of $104.71. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of 13.98 and a beta of 0.80.

Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. The firm had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. Masimo Corporation’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.57 earnings per share.

A number of institutional investors have recently modified their holdings of the stock. Federated Investors Inc. PA boosted its position in shares of Masimo Corporation by 273.4% in the second quarter. Federated Investors Inc. PA now owns 105,366 shares of the medical equipment provider’s stock valued at $9,607,000 after buying an additional 77,148 shares in the last quarter. Fortaleza Asset Management Inc. acquired a new position in shares of Masimo Corporation during the second quarter valued at approximately $106,000. Jennison Associates LLC boosted its position in shares of Masimo Corporation by 111.3% in the second quarter. Jennison Associates LLC now owns 11,650 shares of the medical equipment provider’s stock valued at $1,062,000 after buying an additional 6,137 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Masimo Corporation by 114.7% in the second quarter. BNP Paribas Arbitrage SA now owns 32,879 shares of the medical equipment provider’s stock valued at $2,998,000 after buying an additional 17,565 shares in the last quarter. Finally, Comerica Bank boosted its position in shares of Masimo Corporation by 1.1% in the second quarter. Comerica Bank now owns 35,346 shares of the medical equipment provider’s stock valued at $3,477,000 after buying an additional 395 shares in the last quarter. 84.61% of the stock is owned by institutional investors.

In other Masimo Corporation news, COO Anand Sampath sold 40,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the completion of the transaction, the chief operating officer now owns 20,000 shares of the company’s stock, valued at approximately $1,840,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jon Coleman sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now directly owns 32,201 shares of the company’s stock, valued at approximately $3,139,597.50. The disclosure for this sale can be found here. Insiders sold a total of 115,000 shares of company stock valued at $10,773,180 in the last quarter. 16.60% of the stock is owned by insiders.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Earnings History and Estimates for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.